Systemic lupus erythematosus (SLE) is a chronic multifactorial autoimmune disease that
affects many organs, including the kidney. Lupus nephritis (LN) is a common manifestation …

Objective Management of systemic lupus erythematosus (SLE) is complex and variability in
practices exists. Guidelines have been developed to help improve the management of SLE …

Objective To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing
azathioprine (AZA) and mycophenolate mofetil (MMF) as maintenance therapy of …

Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus
erythematosus (cSLE), leading to significant morbidity. Timely recognition of renal …

Background To perform a systematic review and network meta-analysis (NMA) to compare
the risk of serious infections with immunosuppressive medications and glucocorticoids in …

Background Cyclophosphamide, in combination with corticosteroids, has been first‐line
treatment for inducing disease remission for proliferative lupus nephritis, reducing death at …

Objective To establish agreement on systemic lupus erythematosus (SLE) treatment.
Methods SLE experts (n= 69) were e‐mailed scenarios and indicated preferred treatments …

Systemic lupus erythematosus (SLE) is prevalent in Asia and carries a variable prognosis
among patients across the Asia-Pacific region, which could relate to access to health care …

Lupus nephritis (LN) is an inflammatory condition of the kidneys that encompasses various
patterns of renal disease including glomerular and tubulointerstitial pathology. It is a major …

Background Abelmoschus manihot, a single medicament of traditional Chinese medicine,
has been widely used to treat kidney disease. This is the first randomized controlled clinical …